Bibliographical noteFunding Information:
BioPharma, Astellas Pharma, AstraZeneca, Abbott Laboratories, Janssen Pharmaceuticals, Karius, Merck, Melinta Therapeutics, Roche, Tetraphase Pharmaceuticals, and Seqirus. Dr Patel has received grants from Aqua Pharmaceuticals. Dr Kociolek has received grants from Merck. No other disclosures were reported.
Funding/Support: Drs Heald-Sargent and Kociolek were supported by grants T32AI095207 and K23AI123525, respectively, from the National Institute of Allergy and Infectious Diseases. Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 1. Lu X, Zhang L, Du H, et al; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073 2. Paules C, Subbarao K. Influenza. Lancet. 2017;390(10095):697-708. doi:10.1016/S0140-6736(17)30129-0 3. Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics. J Formos Med Assoc.2020; 119(3):670-673. doi:10.1016/j.jfma.2020.02.009 4. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-657. doi:10.1016/S1473-3099(20) 30232-2 5. L’Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I. Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg Infect Dis. 2020;26(10):26.
Funding/Support: Dr O’Brien’s time was supported by the Health Resources and Services Administration’s Leadership Education in Adolescent Health training program (award HRSA T71MC00006-39-02). Dr Barnes’ time was supported by the Health Resources and Services Administration’s Leadership Education in Neurodevelopmental Disabilities training program (award HRSA T73MC12835). Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. 1. Council on Community Pediatrics. Providing care for children and adolescents facing homelessness and housing insecurity. Pediatrics. 2013;131(6): 1206-1210. doi:10.1542/peds.2013-0645 2. Morton MH, Dworsky A, Matjasko JL, et al. Prevalence and correlates of youth homelessness in the United States. J Adolesc Health. 2018;62(1):14-21. doi:10.1016/j.jadohealth.2017.10.006 3. Haber MG, Toro PA. Homelessness among families, children, and adolescents: an ecological-developmental perspective. Clin Child Fam Psychol Rev. 2004;7(3):123-164. doi:10.1023/B:CCFP.0000045124.09503.f1 4. Gewirtz O’Brien JR, Edinburgh LD, Barnes AJ, McRee A-L. Mental health outcomes among homeless, runaway, and stably housed youth. Pediatrics. 2020;145(4):e20192674. doi:10.1542/peds.2019-2674 5. American Academy of Pediatrics. Adolescence visits. In: Hagan JF, Shaw JS, Duncan PM, eds. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 4th ed. AAP; 2017:731-822. 6. Kessler KMA, Chatterjee D, Shlafer R, Barnes AJ. Adolescent connectedness with parents promotes resilience among homeless youth. Children (Basel). 2018;5(7):96. doi:10.3390/children5070096
PubMed: MeSH publication types
- Journal Article